688443.SS
688443.SS
CNE100006KG8
CHONGQING GENRIX BIOPHARMACEUTI
Loading chart...

Company Profile

-

Related stocks

2595.HK
2595.HK • China
GENFLEET-B
28.6 HKD
1.4B USD 1Y -21%
1952.HK
1952.HK • China
EVEREST MED
29.6 HKD
1.33B USD 1Y -47.1%
6855.HK
6855.HK • China
ASCENTAGE
28.22 HKD
1.34B USD 1Y -61.7%
9887.HK
9887.HK • China
LEADS BIOLABS-B
45.56 HKD
1.15B USD 1Y -37.5%
000990.SZ
000990.SZ • China
CHENGZHI
6.41 CNY
1.17B USD 1Y +22.1%
000403.SZ
000403.SZ • China
PLBIO
9.96 CNY
1.42B USD 1Y -39.1%
301207.SZ
301207.SZ • China
HUALAN VAC
19.88 CNY
1.79B USD 1Y +14.6%
688062.SS
688062.SS • China
MABWELL (SHANGHAI) BIOSCIENCE C
24.78 CNY
1.66B USD 1Y -47.7%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country
China
Region
Asia-Pacific
Sector
Healthcare
Industry
Biotechnology

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
3Y Volatility
52.5% p.a.
Max Drawdown (3Y)
-53.8%
Sharpe Ratio (3Y)
-0.16
Beta Factor
0.62
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
ende